Is UTI Asset Management (UTIAMC) overvalued or fairly valued?

MarketChacha shows UTI Asset Management's valuation in context — a forward P/E of about 15.2, a price-to-book of about 2.5 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is UTI Asset Management's revenue?

UTI Asset Management reported revenue of ₹1,476 Cr for FY2026, with net profit of ₹540 Cr, per official filings.

What is the share price of UTI Asset Management (UTIAMC)?

UTI Asset Management last traded at ₹867.20 (-0.3% on the day), as of 10/19/2026 — a delayed quote shown for education, not investment advice.

UTI Asset Management

UTIAMC · NSE · Asset Management · India

Snapshot

TickerUTIAMC

ExchangeNSE

SectorAsset Management

CountryIndia

Employees1,248

HeadquartersMumbai, India

Websitewww.utiwms.com

Filings tracked7

About UTI Asset Management

UTI Asset Management Company (P) Ltd. is a privately owned investment manager. It manages mutual funds for its clients. The firm invests in money market, fixed income, and public equity markets of India. It employs in-house research while making its investments. UTI Asset Management Company (P) Ltd. was incorporated on November 14, 2002 and is based in Mumbai, India.

Who owns it

Promoters34.7%
Institutions52.6%
Public & other12.6%

57 institutional holders

Ownership breakdown from public market data. Promoter pledge is not included here — that comes from exchange shareholding filings.

Forensic scorecard

Margin has compressed by about 10.3 points over the period — profitability is trending down.

Net margin trend33.9% → 23.6%

Margin has compressed by about 10.3 points over the period — profitability is trending down.

Growth qualityrev 7% · PAT -2%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (Yahoo Finance). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev ₹480 Cr

Next fiscal year

Rev ₹2,163 Cr · EPS 57.02

Est. earnings growth +8.3%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: Yahoo Finance

Annual

Quarterly · last 4

Revenue (FY2026)

₹1,714 Cr

Net margin

23.6%

Revenue CAGR (3y)

+9.9%

Profit CAGR (3y)

-2.6%

Net profit (FY2026)

₹404 Cr

Ask MarketChacha about UTIAMC

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	Net margin
FY2026	₹1,714 Cr	₹404 Cr	23.6%
FY2025	₹1,860 Cr	₹731 Cr	39.3%
FY2024	₹1,744 Cr	₹766 Cr	43.9%
FY2023	₹1,290 Cr	₹437 Cr	33.9%

Quarterly

Period	Revenue	Net profit	Net margin
Q1 FY27	₹585 Cr	₹294 Cr	50.3%
Q4 FY26	₹402 Cr	₹-67 Cr	-16.6%
Q3 FY26	₹518 Cr	₹121 Cr	23.4%
Q2 FY26	₹421 Cr	₹113 Cr	26.8%

Figures as reported, in ₹ (crore). Source: Yahoo Finance.

Filings & announcements

2026

Allotment of ESOP / ESPS
Allotment of 994 equity shares under the UTI AMC Employee Stock Option Scheme - 2007
BSE9/18/2026
Earnings Call Transcript
Transcript of the earnings conference call on financial performance of the Company for the quarter ended 30th June, 2026
BSE7/28/2026
Press Release / Media Release
Press release and investor presentation
BSE7/22/2026
Investor Presentation
Investor presentation and press release
BSE7/22/2026
Outcome Of The Board Meeting Held On 22Nd July, 2026
Outcome of the Board meeting held on 22nd July, 2026
BSE7/22/2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On 22Nd July, 2026
Outcome of the Board meeting of the Company held on 22nd July, 2026
BSE7/22/2026
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of 23rd Annual General Meeting of the Company
BSE7/21/2026material

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.